Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Paola Bagella, Giuseppe VL De Socio, Elena Ricci, Barbara Menzaghi, Canio Martinelli, Nicola Squillace, Paolo Maggi, Giancarlo Orofino, Leonardo Calza, Laura Carenzi, Benedetto Maurizio Celesia, Giovanni Penco, Antonio Di Biagio, Laura Valsecchi, Francesca Vichi, Valeria Colombo, Giustino Parruti, Chiara Dentone, Katia Falasca, Paolo Bonfanti & Giordano Madeddu. (2018) Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project. Infection and Drug Resistance 11, pages 615-623.
Read now
Read now
Mario Cruciani & Marina Malena. (2015) Combination dolutegravir–abacavir–lamivudine in the management of HIV/AIDS: clinical utility and patient considerations. Patient Preference and Adherence 9, pages 299-310.
Read now
Read now
Jose Luis Blanco, Gary Whitlock, Ana Milinkovic & Graeme Moyle. (2015) HIV integrase inhibitors: a new era in the treatment of HIV. Expert Opinion on Pharmacotherapy 16:9, pages 1313-1324.
Read now
Read now
Sheng-Li Li, Peng Xu, Lei Zhang, Gui-Xiang Sun & Zhao-Jun Lu. (2015) Effectiveness and safety of rilpivirine, a non-nucleoside reverse transcriptase inhibitor, in treatment-naive adults infected with HIV-1: a meta-analysis. HIV Clinical Trials 16:1, pages 22-29.
Read now
Read now
Sheng-li Li, Peng Xu, Lei Zhang, Gui-xiang Sun & Zhao-jun Lu. (2014) Effectiveness and Safety of Rilpivirine, a Non-Nucleoside Reverse Transcriptase Inhibitor, in Treatment-Naive Adults Infected with HIV-1: A Meta-analysis. HIV Clinical Trials 15:6, pages 261-268.
Read now
Read now
Articles from other publishers (6)
Amanda Orlando Reis, José H. Rocco SuassunaCynthia B. Cunha, Estevão N. Portela, Valdilea G. Veloso, Beatriz Grinszteijn & Sandra Wagner Cardoso. (2023) Evaluation of Glomerular Filtration Rate Trends in People Living With HIV Corrected by the Baseline Glomerular Filtration Rate. JAIDS Journal of Acquired Immune Deficiency Syndromes 94:1, pages 82-90.
Crossref
Crossref
Karla Cristina Silva Petruccelli, Djane Clarys Baía-da-Silva, Fernando Val, Monica Santos Valões, Nadia Cubas-Vega, Alexandre Vilhena Silva-Neto, Vanderson Sampaio, Aline Alencar, Roberto Pecoits-Filho, Rodrigo Carvalho Moreira, Sandra Wagner Cardoso, Ronaldo I. Moreira, Iuri Costa Leite, José Valdez Madruga, Esper G. Kallas, Paulo R. Alencastro, Brenda Hoagland, Beatriz Grinsztejn, Valdiléa Gonçalves Veloso Santos & Marcus Vinícius Guimarães Lacerda. (2022) Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. AIDS Research and Therapy 19:1.
Crossref
Crossref
Kathrin Golla, Hanna Mannell, Andreas Benesic, Tobias Dreischulte, Eva Grill & Dorothea Strobach. (2022) Feasibility of the MELD score as a screening tool for pharmacists to identify patients with impaired hepatic function at hospital admission. Journal of Clinical Pharmacy and Therapeutics 47:5, pages 676-684.
Crossref
Crossref
Dario Cattaneo & Cristina Gervasoni. (2017) Novel Antiretroviral Drugs in Patients with Renal Impairment: Clinical and Pharmacokinetic Considerations. European Journal of Drug Metabolism and Pharmacokinetics 42:4, pages 559-572.
Crossref
Crossref
Hans-Jürgen Stellbrink. (2017) Gesundheitsvorsorge bei HIV-InfiziertenTreatment of HIV-infected patients: metabolism, bone, cardiovascular — what is part of routine care?. MMW - Fortschritte der Medizin 159:S2, pages 14-23.
Crossref
Crossref
Charles Cazanave, Sandrine Reigadas, Cyril Mazubert, Pantxika Bellecave, Mojgan Hessamfar, Fabien Le Marec, Estibaliz Lazaro, Gilles Peytavin, Mathias Bruyand, Hervé Fleury, François Dabis & Didier Neau. (2015) Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012–2014. Open Forum Infectious Diseases 2:1.
Crossref
Crossref